Cargando…
The EUPHRATES trial (Evaluating the Use of Polymyxin B Hemoperfusion in a Randomized controlled trial of Adults Treated for Endotoxemia and Septic shock): study protocol for a randomized controlled trial
BACKGROUND: Septic shock is common and has unacceptably high morbidity, mortality, and associated cost with numerous failed attempts at developing effective therapies. Endotoxin, one of the most potent mediators of sepsis, is found in high levels in approximately 50% of patients with septic shock. P...
Autores principales: | Klein, David J, Foster, Debra, Schorr, Christa A, Kazempour, Kazem, Walker, Paul M, Dellinger, R Phillip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4066268/ https://www.ncbi.nlm.nih.gov/pubmed/24916483 http://dx.doi.org/10.1186/1745-6215-15-218 |
Ejemplares similares
-
Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial
por: Klein, D. J., et al.
Publicado: (2018) -
Importance of Endotoxin Clearance in Endotoxemic Septic Shock: An Analysis From the Evaluating Use of PolymyxinB Hemoperfusion in a Randomized Controlled Trial of Adults Treated for Endotoxemic Septic Shock (EUPHRATES) Trial
por: Rachoin, Jean-Sebastien, et al.
Publicado: (2020) -
Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial
por: Payen, Didier M., et al.
Publicado: (2015) -
Is polymyxin B-immobilized fiber column ineffective for septic shock? A discussion on the press release for EUPHRATES trial
por: Iba, Toshiaki, et al.
Publicado: (2017) -
Effective use of polymyxin B hemoperfusion in septic shock complicated by urosepsis
por: Malleshappa, P., et al.
Publicado: (2011)